Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
Clinical and Translational Radiation Oncology|August 30, 2021
Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous MelanomaWei Wang, Jessica Louise Smith, Matteo Salvatore Carlino, et al.Chemical Science|February 12, 2025
A descriptor guiding the selection of catalyst supports for ammonia synthesisAndreas Weilhard, Ilya Popov, Emerson C Kohlrausch, et al.BMJ Open|June 30, 2022
Clinical and cost-effectiveness of Knee Arthroplasty versus Joint Distraction for Osteoarthritis (KARDS): protocol for a multicentre, phase III, randomised control trialCerys Joyce Tassinari, Ruchi Higham, Isabelle Louise Smith, et al.Chest|September 11, 2021
Criteria, Processes, and Determination of Competence in Basic Critical Care Echocardiography Training: A Delphi Process Consensus Statement by the Learning Ultrasound in Critical Care (LUCC) InitiativeArvind Rajamani, Laura Galarza, Filippo Sanfilippo, et al.Pigment Cell & Melanoma Research|October 7, 2019
Combined ipilimumab and nivolumab first-line and after BRAF-targeted therapy in advanced melanomaRobert Mason, Helen C Dearden, Bella Nguyen, et al.Melanoma Research|September 27, 2022
Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case seriesJessica Louise Smith, Alexander M Menzies, Justine V Cohen, et al.ACS Omega|August 2, 2021
Indole Inhibitors of MMP-13 for Arthritic DisordersSteven J Taylor, Asitha Abeywardane, Shuang Liang, et al.Journal of Medicinal Chemistry|March 28, 2014
Discovery of 6-phenylpyrimido[4,5-b][1,4]oxazines as potent and selective acyl CoA:diacylglycerol acyltransferase 1 (DGAT1) inhibitors with in vivo efficacy in rodentsBrian M Fox, Kazuyuki Sugimoto, Kiyosei Iio, et al.Bioorganic & Medicinal Chemistry Letters|November 16, 2010
A novel series of IKKβ inhibitors part II: description of a potent and pharmacologically active series of analogsTimothy D Cushing, Vijay Baichwal, Karen Berry, et al.Bioorganic & Medicinal Chemistry Letters|November 16, 2010
A novel series of IKKβ inhibitors part I: Initial SAR studies of a HTS hitTimothy D Cushing, Vijay Baichwal, Karen Berry, et al.Pageof 11